{"title":"The Legal Issues Regarding the Reimbursement of Drugs Used to Treat Muscular Atrophy and the Actual Situation in the Slovak Republic.","authors":"Katarína Zajác Ševcová","doi":"10.1163/15718093-bja10139","DOIUrl":null,"url":null,"abstract":"<p><p>This article explores the legal problems regarding reimbursing drugs used to treat muscular atrophy. The article highlights the importance of insurance coverage for patients with muscular atrophy and the need for more uniform policies. In the Slovak Republic, the state health insurance company refused to reimburse the medicine several times, although it made an exception for other children in the past. The patient asked the civil court to order an urgent measure. The court granted this proposal and ordered the insurance company to pay for the drug Zolgensma. The article analyzes the legal nature of this case considering fundamental human rights.</p>","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":" ","pages":"1-19"},"PeriodicalIF":0.6000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EUROPEAN JOURNAL OF HEALTH LAW","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/15718093-bja10139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0
Abstract
This article explores the legal problems regarding reimbursing drugs used to treat muscular atrophy. The article highlights the importance of insurance coverage for patients with muscular atrophy and the need for more uniform policies. In the Slovak Republic, the state health insurance company refused to reimburse the medicine several times, although it made an exception for other children in the past. The patient asked the civil court to order an urgent measure. The court granted this proposal and ordered the insurance company to pay for the drug Zolgensma. The article analyzes the legal nature of this case considering fundamental human rights.
期刊介绍：
The European Journal of Jewish Studies (EJJS) is the Journal of the European Association for Jewish Studies (EAJS). Its main purpose is to publish high-quality research articles, essays and shorter contributions on all aspects of Jewish Studies. Submissions are all double blind peer-reviewed. Additionally, EJJS seeks to inform its readers on current developments in Jewish Studies: it carries comprehensive review-essays on specific topics, trends and debated questions, as well as regular book-reviews. A further section carries reports on conferences, symposia, and descriptions of research projects in every area of Jewish Studies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
